MDxHealth SA

US$0.16As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:MDXHHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (58.15%)
Div yield —
ROE —
Diagnostics & Research
Beta (5Y) (528,309)
PE TTM —
TSR TTM (96.81%)
Mkt cap US$14.98M
ROIC (16.91%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.157
0.01%
(82.91%)
Hold 1|5|7|8|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
6.05%
1.64%
4.52%
(1.39%)
Revenue$M
0.652
0.661
0.654
0.646
4.85%
2.10%
(3.24%)
(3.76%)
Peers (US$14.98M)
Cap (US$)
PE
86.22M
—
16.16M
7.436x
8.946M
2.587x
16.27M
—
Capital
TTM
5Y
10Y
Leveragex
1.043
0.012
0.011
EBIT/Intx
0.431
0.307
0.289
Own earn%
122.67
(46.80)
(54.83)
Sh yield%
26.09
13.53
14.75
Owners
Insiders/Inst%
8.31
57.96
Short interest%
0.90
SBC / revenue%
3.02
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
4–13
$1 testx
0.1
Incr. ROIC%
23